RU2018120081A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018120081A3 RU2018120081A3 RU2018120081A RU2018120081A RU2018120081A3 RU 2018120081 A3 RU2018120081 A3 RU 2018120081A3 RU 2018120081 A RU2018120081 A RU 2018120081A RU 2018120081 A RU2018120081 A RU 2018120081A RU 2018120081 A3 RU2018120081 A3 RU 2018120081A3
- Authority
- RU
- Russia
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Ecology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382537.7A EP3163303A1 (en) | 2015-11-02 | 2015-11-02 | Methods for apolipoprotein detection |
| EP15382537.7 | 2015-11-02 | ||
| PCT/EP2016/076457 WO2017076919A2 (en) | 2015-11-02 | 2016-11-02 | Methods for apolipoprotein detection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018120081A RU2018120081A (ru) | 2019-12-05 |
| RU2018120081A3 true RU2018120081A3 (ru) | 2020-03-10 |
| RU2763404C2 RU2763404C2 (ru) | 2021-12-28 |
Family
ID=54608470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018120081A RU2763404C2 (ru) | 2015-11-02 | 2016-11-02 | Способы детекции аполипопротеинов |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20180313854A1 (ru) |
| EP (3) | EP3163303A1 (ru) |
| JP (1) | JP6994718B2 (ru) |
| KR (1) | KR102630558B1 (ru) |
| CN (2) | CN119199154A (ru) |
| AU (1) | AU2016348558B2 (ru) |
| CA (1) | CA3003837A1 (ru) |
| DK (1) | DK3274725T3 (ru) |
| ES (1) | ES2728268T3 (ru) |
| HU (1) | HUE042606T2 (ru) |
| MX (1) | MX382446B (ru) |
| PL (1) | PL3274725T3 (ru) |
| PT (1) | PT3274725T (ru) |
| RU (1) | RU2763404C2 (ru) |
| TR (1) | TR201904846T4 (ru) |
| WO (1) | WO2017076919A2 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110234998A (zh) * | 2016-07-21 | 2019-09-13 | 克利夫兰心脏实验室公司 | Hdl相关蛋白质生物标记物组的检测 |
| US20190369113A1 (en) | 2018-06-01 | 2019-12-05 | Laboratory Corporation Of America Holdings | Simplified Biosample Processing for LC-MS/MS |
| CN109212218A (zh) * | 2018-11-07 | 2019-01-15 | 李玉民 | 基于apoa4蛋白胃癌检测试剂盒、及其使用方法 |
| WO2021050880A2 (en) * | 2019-09-13 | 2021-03-18 | Northwestern University | Biomarkers for amyotrophic lateral sclerosis (als) and motor neuron diseases |
| CN110780071A (zh) * | 2019-11-11 | 2020-02-11 | 彭涛 | 一种乙肝相关肝细胞癌的预后检测试剂盒 |
| CN112375138B (zh) * | 2020-11-13 | 2022-12-13 | 中元汇吉生物技术股份有限公司 | 一种重组载脂蛋白e和应用 |
| CN115541568B (zh) * | 2021-06-29 | 2025-07-11 | 厦门红观生物科技有限公司 | 一种泪液试纸上ApoJ提取和定量检测方法及其试剂盒和应用 |
| CN117886933A (zh) * | 2023-12-28 | 2024-04-16 | 上海良润生物医药科技有限公司 | 一种载脂蛋白e检测试剂及其应用 |
| WO2025219956A1 (en) * | 2024-04-18 | 2025-10-23 | Comed Therapeutics Ltd. | Compositions and methods for rna delivery to cells |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772549A (en) * | 1986-05-30 | 1988-09-20 | Biotechnology Research Partners, Ltd. | Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV |
| US5945289A (en) | 1996-12-20 | 1999-08-31 | Lehrer; Steven | Method for detecting prostate cancer by apolipoprotein E (Apo-E) genotyping |
| JP3397066B2 (ja) * | 1996-12-27 | 2003-04-14 | 富士レビオ株式会社 | 免疫学的測定方法を用いたアポ蛋白eフェノタイプの同定方法 |
| AU762931B2 (en) * | 1999-03-16 | 2003-07-10 | Serex, Inc. | Method and device for detection of Apo A, Apo B and the ratio thereof in saliva |
| JP4153873B2 (ja) * | 2001-10-04 | 2008-09-24 | 株式会社 免疫生物研究所 | アルツハイマー危険因子の検出試薬および検出用キットならびにこれらを用いるアルツハイマー危険因子の検出方法 |
| EP1482897A2 (en) * | 2002-02-19 | 2004-12-08 | Ilex Products, Inc. | Aminodiphosphonate apolipoprotein e modulators |
| WO2005072152A2 (en) * | 2004-01-22 | 2005-08-11 | Genaissance Pharmaceuticals, Inc. | Apoc1 genetic markers associated with age of onset of alzheimer's disease |
| JP5229789B2 (ja) * | 2007-02-27 | 2013-07-03 | プリマハム株式会社 | 新規ストレスバイオマーカー及びその用途 |
| WO2009108073A1 (en) * | 2008-02-28 | 2009-09-03 | Auckland Uniservices Limited | Biomarkers for prediction of preeclampsia and/or cardiovascular disease |
| ES2364169B1 (es) * | 2010-02-09 | 2012-07-10 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) | Uso de las isoformas de apo j como biomarcadores de lesión tisular. |
| CA2791648A1 (en) * | 2010-03-01 | 2011-09-09 | The J. David Gladstone Institutes | Antibody specific for apolipoprotein and methods of use thereof |
| US20120009125A1 (en) * | 2010-07-06 | 2012-01-12 | Lombard Jay L | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| WO2013170057A2 (en) * | 2012-05-09 | 2013-11-14 | President And Fellows Of Harvard College | Quantification of lipoproteins |
| ES2759026T3 (es) * | 2013-02-26 | 2020-05-07 | Inst Oftalmologico Fernandez Vega S L | Método para el diagnóstico de glaucoma basándose en la determinación de niveles de proteínas séricas |
-
2015
- 2015-11-02 EP EP15382537.7A patent/EP3163303A1/en not_active Withdrawn
-
2016
- 2016-11-02 KR KR1020187015716A patent/KR102630558B1/ko active Active
- 2016-11-02 TR TR2019/04846T patent/TR201904846T4/tr unknown
- 2016-11-02 CN CN202411019355.5A patent/CN119199154A/zh active Pending
- 2016-11-02 WO PCT/EP2016/076457 patent/WO2017076919A2/en not_active Ceased
- 2016-11-02 ES ES16794966T patent/ES2728268T3/es active Active
- 2016-11-02 DK DK16794966.8T patent/DK3274725T3/en active
- 2016-11-02 AU AU2016348558A patent/AU2016348558B2/en active Active
- 2016-11-02 MX MX2018005448A patent/MX382446B/es unknown
- 2016-11-02 EP EP16794966.8A patent/EP3274725B1/en active Active
- 2016-11-02 EP EP18201037.1A patent/EP3457140A1/en not_active Withdrawn
- 2016-11-02 RU RU2018120081A patent/RU2763404C2/ru active
- 2016-11-02 PL PL16794966T patent/PL3274725T3/pl unknown
- 2016-11-02 US US15/772,515 patent/US20180313854A1/en active Pending
- 2016-11-02 CA CA3003837A patent/CA3003837A1/en active Pending
- 2016-11-02 CN CN201680077646.7A patent/CN108700593A/zh active Pending
- 2016-11-02 JP JP2018541536A patent/JP6994718B2/ja active Active
- 2016-11-02 HU HUE16794966A patent/HUE042606T2/hu unknown
- 2016-11-02 PT PT16794966T patent/PT3274725T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3274725T3 (en) | 2019-04-23 |
| TR201904846T4 (tr) | 2019-04-22 |
| EP3274725A2 (en) | 2018-01-31 |
| CN119199154A (zh) | 2024-12-27 |
| MX2018005448A (es) | 2019-04-04 |
| PL3274725T3 (pl) | 2019-08-30 |
| PT3274725T (pt) | 2019-04-30 |
| AU2016348558A1 (en) | 2018-06-21 |
| CN108700593A (zh) | 2018-10-23 |
| ES2728268T3 (es) | 2019-10-23 |
| JP6994718B2 (ja) | 2022-01-14 |
| EP3457140A1 (en) | 2019-03-20 |
| BR112018008749A8 (pt) | 2019-02-26 |
| MX382446B (es) | 2025-03-13 |
| RU2763404C2 (ru) | 2021-12-28 |
| KR20180081545A (ko) | 2018-07-16 |
| RU2018120081A (ru) | 2019-12-05 |
| EP3274725B1 (en) | 2019-01-09 |
| US20180313854A1 (en) | 2018-11-01 |
| JP2018533022A (ja) | 2018-11-08 |
| HUE042606T2 (hu) | 2019-07-29 |
| WO2017076919A2 (en) | 2017-05-11 |
| KR102630558B1 (ko) | 2024-01-26 |
| AU2016348558B2 (en) | 2022-02-24 |
| EP3163303A1 (en) | 2017-05-03 |
| CA3003837A1 (en) | 2017-05-11 |
| WO2017076919A3 (en) | 2017-06-15 |
| BR112018008749A2 (pt) | 2018-10-30 |